Skip to main content
. 2012 Jan 21;18(3):237–243. doi: 10.3748/wjg.v18.i3.237

Table 4.

Unadjusted and adjusted associations between nonalcoholic fatty liver disease and age, menopause status, hormone replacement therapy, metabolic syndrome and weight gain in 1247 women

Unadjusted odds ratio (95% CI) P values Adjusted odds ratio (95% CI) P values
Age 1.05 (1.02-1.08) 0.001 1.06 (1.02-1.1) 0.004
Menopause 2.26 (0.76-6.69) 0.14 1.22 (0.38-3.99) 0.74
Postmenopausal state 1.8 (1.03-3.15) 0.039 0.72 (0.31-1.66) 0.44
Active hormone replacement therapy 1.56 (0.76-3.19) 0.22 1.32 (0.6-2.88) 0.49
Presence of metabolic syndrome at baseline 9.89 (4.67-20.94) < 0.001 11.7 (5.02-27.25) < 0.001
Weight gain 1.50 (1.30-1.74) < 0.001 1.63 (1.39-1.9) < 0.001

We calculated the odds ratio of each factor for nonalcoholic fatty liver disease in a univariate logistic regression model. The columns to the left indicate unadjusted odds ratio [95% confidence interval (CI)]. We selected all parameters as cofactors in a multivariate logistic regression model. The columns to the right indicate adjusted odds ratio (95% CI).